COMMUNIQUÉS West-GlobeNewswire

Axogen to Participate in the 74th Annual American Society for Surgery of the Hand Meeting
27/08/2019
Updated outcomes data from the RANGER ® Registry’s MATCH SM cohort will be presented during scientific sessions ALACHUA, Fla., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing [...]
Orchard Therapeutics Announces Presentation of Data from Neurometabolic Portfolio at Upcoming Society for the Study of Inborn Errors of Metabolism (SSIEM) 2019 Annual Symposium
27/08/2019
Mucopolysaccharidosis Type I and Metachromatic Leukodystrophy Abstracts Accepted for Oral Presentations BOSTON and LONDON, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial- [...]
RedHill Biopharma to Present at Upcoming Investor Conferences in September
27/08/2019
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019
27/08/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, Aug. 27, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Amarin Provides Overview on Growing Global Attention on REDUCE-IT™ Results and Cardiovascular Risk Management Beyond Cholesterol Management
27/08/2019
Multiple Papers and Presentations Highlight REDUCE-IT and Vascepa ® Potential Mechanisms of Action of Vascepa Becoming Better Understood American Heart Association References REDUCE-IT in Scientific Advisory BEDMINSTER [...]
FDA Provides Guidance on Clinical Pathway to Marketing Application for Revascor in End-Stage Heart Failure Patients With an LVAD
27/08/2019
Primary Endpoint of Confirmatory Trial to be Reduction in Major Mucosal Bleeding Events NEW YORK and MELBOURNE, Australia, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in [...]
New Data From Aslan’s Study of Varlitinib in China Accepted as Late-Breaking Oral Presentation at 2019 CSCO Annual Meeting
27/08/2019
SINGAPORE, Aug. 27, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that a late-breaking abstract detailing [...]
The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing
27/08/2019
WASHINGTON, D.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader [...]
Zealand Pharma relocates headquarters to accommodate growth
27/08/2019
Press Release – No. 18 / 2019 Copenhagen, August 27, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of [...]
The Management Board of JSC Olainfarm prevents fraudulent use of the company's assets
27/08/2019
Large-scale possibly fraudulent activity suspected in the use of the company's assets by former executives of JSC Olainfarm Criminal proceedings have been initiated by the police Suspicious transactions occurred between [...]
Basilea announces completion of patient enrolment in phase 1 study with oral BAL101553 in brain cancer
27/08/2019
Basel, Switzerland, August 27, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the completion of patient enrolment in its phase 1 study with the oral formulation of the novel tumor checkpoint controller [...]
Press release Biocartis NV: Invitation to the Special Shareholders’ Meeting
27/08/2019
PRESS RELEASE: 27 August 2019, 07:00 CEST REGULATED INFORMATION Invitation to the Special Shareholders’ Meeting Mechelen, Belgium, 27 August 2019 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative [...]
Van Leeuwenhoeck Issues Equity Research Report with Strong Buy and Price Target of CHF11-12 per Share
27/08/2019
Geneva, Switzerland, August 27, 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development today announced that the independent life science equity [...]
Santhera Announces Publication by ReveraGen of Positive Phase IIa-Extension Study Results with Vamorolone in Patients with Duchenne Muscular Dystrophy
27/08/2019
Pratteln, Switzerland, August 27, 2019 – Santhera Pharmaceuticals (SIX: SANN) announces publication by ReveraGen of positive study data with vamorolone in patients with Duchenne muscular dystrophy (DMD). Data from 6- [...]
National Research Corporation Declares Quarterly Dividend
26/08/2019
Lincoln, Nebraska, Aug. 26, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 (nineteen cents) per share [...]
Iovance Biotherapeutics to Present at Upcoming Investor Conferences in September
26/08/2019
SAN CARLOS, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL [...]
STERIS to Participate in the Morgan Stanley Global Healthcare Conference
26/08/2019
Dublin, Ireland, Aug. 26, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019 [...]
Wave Life Sciences to Present at the Morgan Stanley Global Healthcare Conference
26/08/2019
CAMBRIDGE, Mass., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating [...]
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
26/08/2019
PLANO, Texas, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that its Board of Directors has decided to explore potential strategic [...]

Pages